{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:17:23Z","timestamp":1791314243543,"version":"4.3.1"},"reference-count":0,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2007,5,4]],"date-time":"2007-05-04T00:00:00Z","timestamp":1178236800000},"content-version":"vor","delay-in-days":3379,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Dermatology"],"published-print":{"date-parts":[[1998,2]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> The availability of an <jats:italic>in vitro<\/jats:italic> test system to replace animal testing of potential irritants is becoming more and more urgent especially in Europe as a consequence of the European Community Cosmetics Directive. To evaluate the ability of Advanced Tissue Sciences'(ATS) ZK1301 skin model to predict the skin irritation potential of surfactants, we performed a pilot validation study utilizing four different laboratories. The <jats:italic>in vitro<\/jats:italic> protocol was designed as a quantitative pre\u2010screen for the clinical patch studies. Sixteen substances, representing various surfactant categories and ranges of irritation potential, were tested. The 3\u2010[4,5\u2010Dimethylthiazol\u20102\u2010yl]\u20102,5\u2010diphenyltetrazolium bromide (MTT) assay was used to quantitate viability <jats:italic>in vitro<\/jats:italic>. we documented the viability of tissues exposed to unknown substances for specific periods. The <jats:italic>in vtiro<\/jats:italic> results were calcuslated as percent distilled water controls (DWC). The time required to reduce the viability of each tissue to 50% of the distilled water controls (T<jats:sub>50<\/jats:sub>) was compared to men erthema and edema scores from the clinical studies by Pearson's correlation. The individual laboratories demonstrated coefficients of 072. The results indicated that the 30 min percent untreated control values best predicted the 24 h clinical patch scores. No statistically significant interlab variability was found. Only one false negative was seen when non\/mild and moderate\/severe irritant categories were assigned according to the <jats:italic>in vitro<\/jats:italic> scores. These results demonstrate that the skin<jats:sup>2<\/jats:sup>\u00ae<jats:italic>in vitro<\/jats:italic> test system may serve as a good screening method prior to clinical patch studdies.<\/jats:p>","DOI":"10.1111\/j.1600-0625.1998.tb00298.x","type":"journal-article","created":{"date-parts":[[2007,5,4]],"date-time":"2007-05-04T14:02:25Z","timestamp":1178287345000},"page":"18-26","source":"Crossref","is-referenced-by-count":18,"title":["Skin<sup>2<\/sup>\u00ae\u2013 an <i>in vitro<\/i> human skin model: the correlation between <i>in vivo<\/i> and <i>in Vitro<\/i> testing of surfactants"],"prefix":"10.1111","volume":"7","author":[{"given":"Janis","family":"Demetrulias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Morhenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bret","family":"Jessee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Hainsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Casterton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Bernhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Decker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,5,4]]},"container-title":["Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0625.1998.tb00298.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0625.1998.tb00298.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T06:33:19Z","timestamp":1698474799000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0625.1998.tb00298.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,2]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,2]]}},"alternative-id":["10.1111\/j.1600-0625.1998.tb00298.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0625.1998.tb00298.x","archive":["Portico"],"relation":{},"ISSN":["0906-6705","1600-0625"],"issn-type":[{"value":"0906-6705","type":"print"},{"value":"1600-0625","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,2]]}}}